Users Coming Off Weight-Loss Injections Gain Back Pounds Four Times Faster Than Those on Conventional Diets

Fresh analysis indicates that individuals who stop using popular weight-loss injections like semaglutide or tirzepatide may regain lost weight at a significantly accelerated pace than those who stop traditional lifestyle programs.

Published data in a prominent medical journal demonstrates that while overweight people often shed about a fifth of their total mass while undergoing treatment, the mass returns at an average rate of 0.8 kg per month upon discontinuation.

"Individuals purchasing such medications need to be informed of the danger of fast weight regain when the therapy is stopped," stated lead investigator Dr. Susan Jebb.

That rate of regain suggests a return to starting weight in about a year and a half.

Analyzing Approaches

The research, which reviewed dozens of trials involving thousands of patients, contrasted the outcomes of GLP-1 agonists with older methods.

Scientists point out that people who shed pounds through dieting typically have a more gradual creep back—around 0.1 kg a month—once they finish.

Understanding the Rapid Rebound

Nutrition scientists suggest the way of the jabs is key to understanding the accelerated rebound.

These medications imitate a natural hormone called glucagon-like peptide-1, which moderates hunger.

"Artificially providing GLP-1 concentrations far above than normal could lead to the system to generate a reduced amount of its endogenous hormone, and could diminish sensitivity to its actions," said Dr. Adam Collins, a nutrition specialist.

"Stopping of this GLP-1 'fix' means appetite is uncontrolled, making overeating far more likely."

A Chronic Condition?

The NHS recommend the jabs for people with weight-linked medical conditions, accompanied by prescribed lifestyle changes.

Many experts say that, given the likelihood of relapse, the treatment should be considered long-term.

This opinion is reinforced by pharmaceutical companies, who state that the findings "emphasize the persistent nature of excess weight," similar to managing diseases like hypertension.

User Experiences

Users who have stopped the jabs explain a sudden resurgence of hunger.

"It felt as if a trigger flipping and you become ravenous," described an individual.

This challenge is worsened if patients have not established lasting lifestyle or habit changes during treatment.

Growing Use

Recent estimates show that a significant number of adults in the UK have used these injections in the past year, with desire continuing to grow.

• Adoption is more common among women compared to men.
• The middle-aged demographic shows the greatest level of interest.
• Many access the medications through private healthcare rather than public health services.

Ultimately, researchers caution that while the jabs are effective tools for weight loss, they are not a standalone solution and long-term success relies on ongoing behavioural support.